A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
The New York Times reports on new gene therapy efforts to treat sickle-cell disease.
A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.
New Scientist reports that researchers have tested an ALS gene therapy in a mouse model of disease.
The San Diego Union-Tribune reports on the difficulties health insurers face with new gene and cell therapies.
The researchers characterized how gene therapy affects the immune cell repertoires and microbiomes of X-linked severe combined immunodeficiency patients.
The Wall Street Journal looks into the cost of new gene therapies.
In PNAS this week: DNA vaccine-based approach for Duchenne muscular dystrophy tested in mice, antimicrobial found in bear saliva, and more.
In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.
Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.
The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.
Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.
In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.